Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Alignment Healthcare, Inc. stock logo
ALHC
Alignment Healthcare
$5.01
-3.7%
$5.33
$4.46
$9.20
$946.78M1.3877,445 shs832,903 shs
Green Thumb Industries Inc. stock logo
GTBIF
Green Thumb Industries
$12.01
-2.9%
$13.27
$6.42
$15.51
$2.60B1.67397,006 shs143,116 shs
NuVasive, Inc. stock logo
NUVA
NuVasive
$39.75
$39.64
$35.17
$49.53
$2.08B1.071.16 million shsN/A
Xenon Pharmaceuticals Inc. stock logo
XENE
Xenon Pharmaceuticals
$40.01
+0.3%
$44.61
$27.99
$50.99
$3.01B1.15304,533 shs394,989 shs
7 Stocks to Buy And Hold Forever Cover

Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Alignment Healthcare, Inc. stock logo
ALHC
Alignment Healthcare
-3.65%+6.37%+6.14%-31.37%-5.83%
Green Thumb Industries Inc. stock logo
GTBIF
Green Thumb Industries
-2.91%-3.92%-13.66%-6.61%+71.57%
NuVasive, Inc. stock logo
NUVA
NuVasive
0.00%0.00%0.00%0.00%-7.39%
Xenon Pharmaceuticals Inc. stock logo
XENE
Xenon Pharmaceuticals
+0.33%-3.15%-9.07%-11.19%+1.57%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Alignment Healthcare, Inc. stock logo
ALHC
Alignment Healthcare
3.0655 of 5 stars
4.24.00.00.00.03.30.6
Green Thumb Industries Inc. stock logo
GTBIF
Green Thumb Industries
3.6833 of 5 stars
3.53.00.00.03.20.83.1
NuVasive, Inc. stock logo
NUVA
NuVasive
1.9302 of 5 stars
3.30.00.00.00.00.03.1
Xenon Pharmaceuticals Inc. stock logo
XENE
Xenon Pharmaceuticals
1.686 of 5 stars
3.52.00.00.02.12.50.0

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Alignment Healthcare, Inc. stock logo
ALHC
Alignment Healthcare
2.44
Hold$9.3887.13% Upside
Green Thumb Industries Inc. stock logo
GTBIF
Green Thumb Industries
3.00
Buy$47.33294.12% Upside
NuVasive, Inc. stock logo
NUVA
NuVasive
2.50
Moderate Buy$51.3329.14% Upside
Xenon Pharmaceuticals Inc. stock logo
XENE
Xenon Pharmaceuticals
3.00
Buy$59.4448.57% Upside

Current Analyst Ratings

Latest GTBIF, XENE, ALHC, and NUVA Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/12/2024
Xenon Pharmaceuticals Inc. stock logo
XENE
Xenon Pharmaceuticals
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$62.00
4/10/2024
Xenon Pharmaceuticals Inc. stock logo
XENE
Xenon Pharmaceuticals
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$65.00
3/6/2024
Alignment Healthcare, Inc. stock logo
ALHC
Alignment Healthcare
William Blair
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform
3/6/2024
Alignment Healthcare, Inc. stock logo
ALHC
Alignment Healthcare
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageUnderweight$4.50
3/6/2024
Alignment Healthcare, Inc. stock logo
ALHC
Alignment Healthcare
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Neutral$12.00 ➝ $6.00
3/1/2024
Xenon Pharmaceuticals Inc. stock logo
XENE
Xenon Pharmaceuticals
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$56.00 ➝ $55.00
3/1/2024
Xenon Pharmaceuticals Inc. stock logo
XENE
Xenon Pharmaceuticals
Wedbush
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$46.00 ➝ $51.00
3/1/2024
Xenon Pharmaceuticals Inc. stock logo
XENE
Xenon Pharmaceuticals
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$50.00 ➝ $62.00
2/29/2024
Green Thumb Industries Inc. stock logo
GTBIF
Green Thumb Industries
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$11.00 ➝ $15.50
2/28/2024
Alignment Healthcare, Inc. stock logo
ALHC
Alignment Healthcare
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$9.00 ➝ $8.50
1/24/2024
Alignment Healthcare, Inc. stock logo
ALHC
Alignment Healthcare
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$11.00
(Data available from 4/23/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Alignment Healthcare, Inc. stock logo
ALHC
Alignment Healthcare
$1.82B0.52N/AN/A$0.84 per share5.96
Green Thumb Industries Inc. stock logo
GTBIF
Green Thumb Industries
$1.05B2.40$0.63 per share18.99$8.10 per share1.48
NuVasive, Inc. stock logo
NUVA
NuVasive
$1.23B1.70$4.96 per share8.01$17.02 per share2.34
Xenon Pharmaceuticals Inc. stock logo
XENE
Xenon Pharmaceuticals
$9.43M320.04N/AN/A$14.18 per share2.82

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Alignment Healthcare, Inc. stock logo
ALHC
Alignment Healthcare
-$148.02M-$0.79N/AN/AN/A-8.12%-75.64%-20.36%5/2/2024 (Confirmed)
Green Thumb Industries Inc. stock logo
GTBIF
Green Thumb Industries
$36.27M$0.1580.0731.61N/A3.44%2.13%1.45%5/1/2024 (Estimated)
NuVasive, Inc. stock logo
NUVA
NuVasive
$40.41M$0.5079.5015.35N/A2.32%12.17%4.88%N/A
Xenon Pharmaceuticals Inc. stock logo
XENE
Xenon Pharmaceuticals
-$182.39M-$2.72N/AN/AN/AN/A-25.18%-23.99%5/14/2024 (Estimated)

Latest GTBIF, XENE, ALHC, and NUVA Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/2/2024N/A
Alignment Healthcare, Inc. stock logo
ALHC
Alignment Healthcare
-$0.24N/A+$0.24N/AN/AN/A  
2/29/2024Q4 2023
Xenon Pharmaceuticals Inc. stock logo
XENE
Xenon Pharmaceuticals
-$0.76-$0.64+$0.12-$0.64$2.30 millionN/A    
2/28/2024Q4 2023
Green Thumb Industries Inc. stock logo
GTBIF
Green Thumb Industries
$0.05$0.01-$0.04$0.01$270.07 million$278.23 million    
2/27/2024Q4 2023
Alignment Healthcare, Inc. stock logo
ALHC
Alignment Healthcare
-$0.22-$0.25-$0.03-$0.25$444.56 million$465.39 million    

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Alignment Healthcare, Inc. stock logo
ALHC
Alignment Healthcare
N/AN/AN/AN/AN/A
Green Thumb Industries Inc. stock logo
GTBIF
Green Thumb Industries
N/AN/AN/AN/AN/A
NuVasive, Inc. stock logo
NUVA
NuVasive
N/AN/AN/AN/AN/A
Xenon Pharmaceuticals Inc. stock logo
XENE
Xenon Pharmaceuticals
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Alignment Healthcare, Inc. stock logo
ALHC
Alignment Healthcare
1.02
1.84
1.84
Green Thumb Industries Inc. stock logo
GTBIF
Green Thumb Industries
N/A
2.72
1.82
NuVasive, Inc. stock logo
NUVA
NuVasive
0.50
1.25
0.65
Xenon Pharmaceuticals Inc. stock logo
XENE
Xenon Pharmaceuticals
N/A
23.65
23.65

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Alignment Healthcare, Inc. stock logo
ALHC
Alignment Healthcare
86.19%
Green Thumb Industries Inc. stock logo
GTBIF
Green Thumb Industries
0.09%
NuVasive, Inc. stock logo
NUVA
NuVasive
N/A
Xenon Pharmaceuticals Inc. stock logo
XENE
Xenon Pharmaceuticals
95.45%

Insider Ownership

CompanyInsider Ownership
Alignment Healthcare, Inc. stock logo
ALHC
Alignment Healthcare
6.30%
Green Thumb Industries Inc. stock logo
GTBIF
Green Thumb Industries
11.90%
NuVasive, Inc. stock logo
NUVA
NuVasive
0.53%
Xenon Pharmaceuticals Inc. stock logo
XENE
Xenon Pharmaceuticals
5.43%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Alignment Healthcare, Inc. stock logo
ALHC
Alignment Healthcare
1,536188.98 million177.07 millionOptionable
Green Thumb Industries Inc. stock logo
GTBIF
Green Thumb Industries
4,600210.36 million185.33 millionNot Optionable
NuVasive, Inc. stock logo
NUVA
NuVasive
3,00052.45 million52.17 millionOptionable
Xenon Pharmaceuticals Inc. stock logo
XENE
Xenon Pharmaceuticals
25175.43 million71.34 millionOptionable

GTBIF, XENE, ALHC, and NUVA Headlines

SourceHeadline
Federated Hermes Inc. Invests $15.96 Million in Xenon Pharmaceuticals Inc. (NASDAQ:XENE)Federated Hermes Inc. Invests $15.96 Million in Xenon Pharmaceuticals Inc. (NASDAQ:XENE)
marketbeat.com - April 23 at 5:35 AM
Investors Purchase High Volume of Put Options on Xenon Pharmaceuticals (NASDAQ:XENE)Investors Purchase High Volume of Put Options on Xenon Pharmaceuticals (NASDAQ:XENE)
americanbankingnews.com - April 18 at 3:04 AM
Xenon Pharmaceuticals Showcases XEN1101 at the American Academy of Neurology 2024 Annual MeetingXenon Pharmaceuticals Showcases XEN1101 at the American Academy of Neurology 2024 Annual Meeting
globenewswire.com - April 16 at 8:30 AM
Xenon Pharmaceuticals Inc. (NASDAQ:XENE) Given Consensus Rating of "Buy" by AnalystsXenon Pharmaceuticals Inc. (NASDAQ:XENE) Given Consensus Rating of "Buy" by Analysts
americanbankingnews.com - April 16 at 2:34 AM
Xenon Pharmaceuticals (NASDAQ:XENE) Given "Buy" Rating at Needham & Company LLCXenon Pharmaceuticals (NASDAQ:XENE) Given "Buy" Rating at Needham & Company LLC
americanbankingnews.com - April 14 at 3:36 AM
Needham & Company LLC Reiterates Buy Rating for Xenon Pharmaceuticals (NASDAQ:XENE)Needham & Company LLC Reiterates Buy Rating for Xenon Pharmaceuticals (NASDAQ:XENE)
marketbeat.com - April 12 at 8:14 AM
Xenon Pharmaceuticals Inc (XENE)Xenon Pharmaceuticals Inc (XENE)
investing.com - April 10 at 12:10 PM
Xenon Pharmaceuticals to Present at the 2024 Bloom Burton & Co. Healthcare Investor ConferenceXenon Pharmaceuticals to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference
globenewswire.com - April 10 at 8:30 AM
Xenon Pharmaceuticals to Present at the 23rd Annual Needham Virtual Healthcare ConferenceXenon Pharmaceuticals to Present at the 23rd Annual Needham Virtual Healthcare Conference
globenewswire.com - April 4 at 4:01 PM
SG Americas Securities LLC Sells 38,146 Shares of Xenon Pharmaceuticals Inc. (NASDAQ:XENE)SG Americas Securities LLC Sells 38,146 Shares of Xenon Pharmaceuticals Inc. (NASDAQ:XENE)
marketbeat.com - April 2 at 4:18 AM
Assenagon Asset Management S.A. Sells 47,962 Shares of Xenon Pharmaceuticals Inc. (NASDAQ:XENE)Assenagon Asset Management S.A. Sells 47,962 Shares of Xenon Pharmaceuticals Inc. (NASDAQ:XENE)
marketbeat.com - April 1 at 4:43 AM
Xenon Pharmaceuticals IncXenon Pharmaceuticals Inc
money.usnews.com - March 21 at 10:13 AM
Xenon Pharmaceuticals (NASDAQ:XENE) Is In A Good Position To Deliver On Growth PlansXenon Pharmaceuticals (NASDAQ:XENE) Is In A Good Position To Deliver On Growth Plans
finance.yahoo.com - March 19 at 8:26 AM
XENE Apr 2024 47.500 putXENE Apr 2024 47.500 put
finance.yahoo.com - March 16 at 1:48 PM
Xenon Pharmaceuticals to Present at Stifel 2024 Virtual CNS DaysXenon Pharmaceuticals to Present at Stifel 2024 Virtual CNS Days
globenewswire.com - March 12 at 4:01 PM
Insider Selling: Xenon Pharmaceuticals Inc. (NASDAQ:XENE) EVP Sells 7,137 Shares of StockInsider Selling: Xenon Pharmaceuticals Inc. (NASDAQ:XENE) EVP Sells 7,137 Shares of Stock
insidertrades.com - March 11 at 6:41 AM
Insider Sell: EVP, Strategy & Innovation Sherrington Robin Sells 7,137 Shares of Xenon ...Insider Sell: EVP, Strategy & Innovation Sherrington Robin Sells 7,137 Shares of Xenon ...
finance.yahoo.com - March 9 at 12:06 AM
Xenon Pharmaceuticals to Present at Leerink Partners Global Biopharma Conference 2024Xenon Pharmaceuticals to Present at Leerink Partners Global Biopharma Conference 2024
globenewswire.com - March 5 at 4:01 PM
Buy Rating Affirmed for Xenon Pharmaceuticals on Strong Neurological Pipeline ProgressBuy Rating Affirmed for Xenon Pharmaceuticals on Strong Neurological Pipeline Progress
markets.businessinsider.com - March 5 at 10:33 AM
Xenon Pharmaceuticals Inc. (XENE) Q4 2023 Earnings Call TranscriptXenon Pharmaceuticals Inc. (XENE) Q4 2023 Earnings Call Transcript
seekingalpha.com - March 2 at 2:52 PM
Xenon Pharmaceuticals Inc. (NASDAQ:XENE) Q4 2023 Earnings Call TranscriptXenon Pharmaceuticals Inc. (NASDAQ:XENE) Q4 2023 Earnings Call Transcript
finance.yahoo.com - March 2 at 9:52 AM
Xenon Pharmaceuticals Inc.: Xenon Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate UpdateXenon Pharmaceuticals Inc.: Xenon Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
finanznachrichten.de - March 1 at 2:30 PM
Xenon (XENE) Q4 Earnings Top Estimates, Pipeline in FocusXenon (XENE) Q4 Earnings Top Estimates, Pipeline in Focus
zacks.com - March 1 at 9:36 AM
Buy Rating Justified by Xenon Pharmaceuticals’ Advanced Epilepsy Program and Growth Prospects in NeuroscienceBuy Rating Justified by Xenon Pharmaceuticals’ Advanced Epilepsy Program and Growth Prospects in Neuroscience
markets.businessinsider.com - March 1 at 9:23 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

Alignment Healthcare logo

Alignment Healthcare

NASDAQ:ALHC
Alignment Healthcare, Inc., a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.
Green Thumb Industries logo

Green Thumb Industries

OTCMKTS:GTBIF
Green Thumb Industries Inc. manufactures, distributes, markets, and sells of cannabis products for medical and adult-use in the United States. It operates through two segments, Retail and Consumer Packaged Goods. The company offers cannabis flower; processed and packaged products, including pre-rolls, concentrates, vapes, capsules, tinctures, edibles, topicals, and other cannabis-related products under the &Shine, Beboe, Dogwalkers, Doctor Solomon's, Good Green, incredibles, and RHYTHM brands. It distributes its products primarily to third-party retail customers and sells finished products directly to consumers in its own retail stores, as well as direct-to consumer delivery channel. Green Thumb Industries Inc. was founded in 2014 and is headquartered in Chicago, Illinois.
NuVasive logo

NuVasive

NASDAQ:NUVA
NuVasive, Inc., a medical technology company, develops, manufactures, and sells procedural solutions for spine surgery. It provides surgical access instruments, including Maxcess integrated split-blade retractor system that enable less-invasive surgical techniques by minimizing soft tissue disruption during spine surgery; specialized spinal implants to advance spinal fusion by enhancing the osseointegration and biomechanical properties of implant materials, including porous titanium and porous polyetheretherketone; and fixation system that facilitates the preservation and restoration of patient alignment. The company also offers cervical total disc replacement technology for cervical spinal fusion surgery; neuromonitoring systems, which use proprietary software-driven nerve detection and avoidance technology, and its intraoperative neuromonitoring services and support; and Pulse platform, a software ecosystem that integrates multiple hardware technologies into a single, condensed footprint in the operating room. In addition, it provides expandable growing rod implant systems for the treatment of early-onset scoliosis; various biologics that are used to aid in the spinal fusion or bone healing process; Precice, an intramedullary device that utilizes the MAGEC technology to non-invasively lengthen the femur and tibia; and onsite and remote monitoring of the neurological systems of patients undergoing spinal and brain-related surgeries. The company sells its products to patients, surgeons, hospitals, and insurers through independent sales agents, directly employed sales personnel, and distributors in the United States and internationally. NuVasive, Inc. was incorporated in 1997 and is headquartered in San Diego, California. As of September 1, 2023, NuVasive, Inc. operates as a subsidiary of Globus Medical, Inc.
Xenon Pharmaceuticals logo

Xenon Pharmaceuticals

NASDAQ:XENE
Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, a Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epileptic encephalopathy; and XEN1101, a Kv7 potassium channel opener, which is in Phase II clinical trial for the treatment of epilepsy and other neurological disorders. The company's product candidates also comprise NBI-921352, a selective Nav1.6 sodium channel inhibitor that is in Phase II clinical trials for the treatment of SCN8A developmental and epileptic encephalopathy, and other indications, including adult focal epilepsy. It has a license and collaboration agreement with the Neurocrine Biosciences, Inc. to develop treatments for epilepsy. The company was incorporated in 1996 and is headquartered in Burnaby, Canada.